ADMA Biologics Inc (NASDAQ:ADMA)

4.96
Delayed Data
As of Jun 19
 -0.16 / -3.13%
Today’s Change
2.01
Today|||52-Week Range
5.70
+54.52%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 10.50, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +111.69% increase from the last price of 4.96.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$6.4M
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.24%
 
 
 
 
 
 
Growthannually 33.51%
 
 
 
 
 
 

Sales

Growthquarterly 58.24%
 
 
 
 
 
 
Growthannually 12.07%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.